Ocular Co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation

• Egile Nagusiak: Elissavet Taka (Egilea), Christina Karavasili (Egilea), Nikolaos Bouropoulos (Egilea), Thomas Moschakis (Egilea), Dimitrios D. Andreadis (Egilea), Constantinos K. Zacharis (Egilea), Dimitrios G. Fatouros (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2020-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Effective pharmacotherapy during glaucoma treatment depends on interventions that reduce intraocular pressure (IOP) and retain the IOP lowering effect for sufficient time so as to reduce dosing frequency and enhance patient adherence. Combination anti-glaucoma therapy and dosage forms that increase...